Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cysteine residues are the sulfur-containing amino acid building blocks present within proteins. They are unique due to their thiol (-SH) side chain, which is chemically reactive and can undergo various post-translational modifications, including oxidation to form disulfide bonds (cystine), S-glutathionylation, S-nitrosylation, and conjugation with metals (as seen in zinc fingers)[1][2][4][5][6]. Disulfide bonds formed between cysteine residues greatly stabilize protein tertiary and quaternary structures in the oxidizing extracellular environment, contribute to protein rigidity, and can be essential for biological activity[1][3][4][5]. Cysteine's thiol group also acts as a nucleophile in many enzyme active sites (such as proteases, oxidoreductases), making such cysteines targets for regulation by redox changes or for covalent inhibition by some drugs[2][6][7]. Post-translational modifications of cysteine are major mediators of redox-sensing and signal transduction, especially in response to oxidative stress[6][7]. These modifications can reversibly or irreversibly alter protein function, and dysregulation is implicated in diseases such as diabetes, cancer, and neurodegeneration[2][6]. Cysteine residues themselves, however, are not considered a drug target; instead, specific proteins containing catalytically or structurally important cysteines can be, making “cysteine residues in proteins” an incorrect designation for a canonical therapeutic target.
Covalent modification of cysteine thiols (inhibition or activation of enzyme activity) - Disulfide bond reduction/oxidation - Alteration of redox signaling
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cysteine residue in protein.